Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15

CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece

Total article views   HTML views PDF downloads Totals
3,516 Dovepress* 3,339+ 162 3,501
PubMed Central* 177 81 258
Totals 3,516 243 3,759
*Since 17 February 2023

View citations on PubMed Central and Google Scholar